BioNeutra International, Ltd.

BIMOOTCIndustrials

$0.00

+$0.00(+0.00%)

Market Cap$16343

P/E Ratio—

52W High$0.0026

52W Low$0.0001

Avg Volume169

Open$0.00

Beta3.42

Overview

BioNeutra International, Ltd. (BIMO) Revenue

Annual & quarterly revenue history · segment & region breakdown

BIMO · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

BioNeutra International, Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

—

0 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · BioNeutra International, Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

BIMO revenue by year · BIMO revenue history · BIMO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income BioNeutra International, Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

BioNeutra International, Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from BioNeutra International, Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

BIMO revenue · 4 questions

BIMO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

BIMO revenueBIMO annual revenuewhat is BIMO revenueBIMO TTM revenue

▸ Source: FMP · BioNeutra International, Ltd. SEC filings · GAAP · BioNeutra International, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026